Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HIRU | US
-0.00
-16.67%
Healthcare
Biotechnology
30/06/2024
18/03/2026
0.00
0.00
0.00
0.00
Hiru Corporation through its subsidiary produces Chinese herbs for the naturopathic industry in China. It manufactures herbal supplements containing ginseng. The company sells and distributes pharmaceuticals health and beauty products dietary and herbal supplements and other healthcare products. It manufactures approximately 120 extracts used in traditional Chinese medicine. Hiru Corporation sells its products through regional distributors as well as directly to the hospitals clinics and pharmacies in China. Hiru Corporation was formerly known as Phoenix Restaurant Group Inc. and changed its name to Hiru Corporation in November 2008. The company is based in Phoenix Arizona.
View LessLow Market Beta (-0.4 to 0.8)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
360.4%1 month
284.4%3 months
212.4%6 months
230.4%-
-
-
2.63
0.71
-0.07
0.01
-
5.92M
4.73M
4.73M
-
8.99
-
-
19.68
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.00
Range1M
0.01
Range3M
0.01
Rel. volume
0.49
Price X volume
72.13K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Curis Inc | CRIS | Biotechnology | 0.8151 | 4.87M | -8.58% | n/a | -6039.91% |
| Xenetic Biosciences Inc | XBIO | Biotechnology | 3.12 | 4.81M | 0.00% | n/a | 0.00% |
| Evogene Ltd | EVGN | Biotechnology | 0.8479 | 4.74M | -2.77% | n/a | 26.41% |
| SNTI | SNTI | Biotechnology | 0.9703 | 4.44M | -0.99% | n/a | 80.96% |
| Brainstorm Cell Therapeutics Inc | BCLI | Biotechnology | 0.83 | 4.41M | -1.19% | n/a | -27.28% |
| Immuron Limited | IMRN | Biotechnology | 0.711 | 4.32M | -5.21% | n/a | 1.37% |
| BioCardia Inc | BCDA | Biotechnology | 1.23 | 4.31M | -3.91% | n/a | -58.03% |
| Aptorum Group Limited | APM | Biotechnology | 0.7829 | 4.28M | -0.41% | n/a | 13.53% |
| Neurotrope Inc | NTRP | Biotechnology | 2.65 | 4.20M | -6.36% | n/a | 0.00% |
| QNCX | QNCX | Biotechnology | 0.097 | 4.20M | -2.02% | n/a | 30.62% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4291 | 4.08M | 31.30% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.3 | 1.27M | -1.29% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.07 | - | Cheaper |
| Ent. to Revenue | 0.01 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 212.39 | - | Riskier |
| Debt to Equity | 2.63 | -1.23 | Expensive |
| Debt to Assets | 0.71 | 0.25 | Expensive |
| Market Cap | 4.73M | - | Emerging |